ClinVar Miner

Submissions for variant NM_001356.5(DDX3X):c.1490C>T (p.Ala497Val)

dbSNP: rs796052236
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 5
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Ambry Genetics RCV001265760 SCV001443929 pathogenic Inborn genetic diseases 2015-09-29 criteria provided, single submitter clinical testing
Labcorp Genetics (formerly Invitae), Labcorp RCV001857666 SCV002232023 pathogenic not provided 2021-12-08 criteria provided, single submitter clinical testing This sequence change replaces alanine, which is neutral and non-polar, with valine, which is neutral and non-polar, at codon 497 of the DDX3X protein (p.Ala497Val). This variant is not present in population databases (gnomAD no frequency). This missense change has been observed in individual(s) with clinical features of DDX3X-related conditions (PMID: 32135084; Invitae). In at least one individual the variant was observed to be de novo. ClinVar contains an entry for this variant (Variation ID: 207818). Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Not Available"; Align-GVGD: "Class C55"). For these reasons, this variant has been classified as Pathogenic.
Revvity Omics, Revvity RCV003144153 SCV003828818 likely pathogenic Intellectual disability, X-linked 102 2022-06-08 criteria provided, single submitter clinical testing
Lifecell International Pvt. Ltd RCV003144153 SCV003922404 likely pathogenic Intellectual disability, X-linked 102 criteria provided, single submitter clinical testing A Heterozygous Missense variant c.1490C>T in Exon 13 of the DDX3X gene that results in the amino acid substitution p.Ala497Val was identified. The observed variant is novel in gnomAD exomes and genomes, respectively. The severity of the impact of this variant on the protein is high, based on the effect of the protein and REVEL score. Rare Exome Variant Ensemble Learner (REVEL) is an ensembl method for predicting the pathogenicity of missense variants based on a combination of scores from 13 individual tools: MutPred, FATHMM v2.3, VEST 3.0, PolyPhen-2, SIFT, PROVEAN, MutationAssessor, MutationTaster, LRT, GERP++, SiPhy, phyloP, and phastCons. The REVEL score for an individual missense variant can range from 0 to 1, with higher scores reflecting greater likelihood that the variant is disease-causing. ClinVar has also classified this variant as Pathogenic [Variation ID: 207818]. The observed missense change has been previously observed in individual(s) with clinical features of DDX3X-related conditions (Lennox AL, et.al., 2020). For these reasons, this variant has been classified as Likely Pathogenic.
CeGaT Center for Human Genetics Tuebingen RCV001857666 SCV005330406 pathogenic not provided 2024-08-01 criteria provided, single submitter clinical testing DDX3X: PS2, PM1, PM2, PM5, PS4:Moderate, PP2

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.